Transaction tax

Intellectual Property and Tax – Collaboration is Key to Mitigate Business Risk (Podcast) – Intellectual Property

United States: IP and tax – Collaboration is key to mitigating business risk (Podcast)

To print this article, all you need to do is be registered or log in to Mondaq.com.

Intellectual property is one of the main drivers of the profitability of a multinational company. Because intellectual property is inherently mobile, intellectual property tax planning routinely involves cross-company licensing, cost sharing, and other joint ownership structures. Moving intellectual property as part of a tax planning strategy can generate significant net worth, but doing so without the coordination of intellectual property and tax expertise creates significant risks. These questions are also an essential part of any merger, acquisition, reorganization or joint venture.

Whenever a transaction involves either the acquisition or migration of intellectual property assets, it often results in decisions between affiliates that involve both tax and intellectual property issues. Failure to resolve both tax and intellectual property issues can result in harm to the business. If not done correctly, a business may not have standing to sue for lost profits or obtain an injunction. In addition to these intellectual property risks, cross-border intellectual property structures come with increased audit risk, as demonstrated by recent U.S. Tax Court cases in which the interplay between tax and intellectual property is often an integral part of the result.

Please join James R. Ferguson, intellectual property partner of Mayer Brown, and tax partners Jenny Austin and Michael Lebovitz as they discuss critical considerations and best practices for these transactions, answering questions such as :

  • How can a company optimize its tax situation by investing its intellectual property assets?
  • What transfer pricing issues arise when a company transfers ownership of its patents from one jurisdiction to another?
  • How does cost sharing affect the tax treatment of intellectual property assets developed by joint ventures?
  • What tax disputes are currently being raised regarding the ownership of intellectual property assets?
  • What patent enforcement issues can arise when a company transfers ownership of its intellectual property assets from one jurisdiction to another?
  • How can a company best design its cross-affiliate licensing structure to protect the enforcement options of its patent portfolio?
  • How should patent-holding companies draft employment contracts to secure ownership of all future inventions?

Visit us at mayerbrown.com

Mayer Brown is a global provider of legal services comprised of law firms that are separate entities (the “Mayer Brown Firms”). The Mayer Brown firms are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, two limited liability companies established in Illinois in the United States; Mayer Brown International LLP, a limited company incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales under number OC 303359); Mayer Brown, a SELAS based in France; Mayer Brown JSM, a partnership of Hong Kong and its associated entities in Asia; and Tauil & Checker Advogados, a Brazilian legal partnership with which Mayer Brown is associated. “Mayer Brown” and the Mayer Brown logo are registered trademarks of Mayer Brown law firms in their respective jurisdictions.

© Copyright 2020. Mayer Brown Practices. All rights reserved.

This article by Mayer Brown provides information and commentary on interesting legal issues and developments. The foregoing is not a complete treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action regarding the matters discussed here.

POPULAR ARTICLES ON: United States Intellectual Property

Brand comparison guide

Obhan & Associates

Trademark comparison guide for the jurisdiction of India, see our comparison guides section to compare across multiple countries

The virtues of claiming precisely what the FDA has approved!

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

At Teva Pharma. USA, Inc. v. Corcept Therapeutics, Inc., No. 21-1360 (Fed. Cir. Dec. 7, 2021), Federal Circuit upheld the final written decision of the Patent Trial and Appeal Board (“the Commission”) stating Teva failed to show that all of the allegations challenged in PGR2019-00048 would have been obvious.

Top Ten TTAB Decisions of 2021 (Part I)

Wolf, Greenfield & Sacks, PC

The TTABlogger has once again chosen the ten (10) TTAB (Tee-Tee-Ā-Bee) decisions that it considers to be the most important and/or interesting from the previous calendar year (2021).